Iridex SEC Filings

IRIDEX CORP’s 10% owner Novel Inspiration International Co., Ltd. reported receiving additional common shares. On 10/01/2025, Novel Inspiration acquired 97,610 shares of IRIDEX common stock at a reported price of $0.0000 per share, increasing its beneficial ownership to 234,943 shares held directly.

The shares were issued as a quarterly interest payment on a Convertible Promissory Note that IRIDEX had issued to Novel Inspiration on March 19, 2025. The Form 4 is filed jointly by Novel Inspiration and Shih-Yao David Lin, who is the sole officer, director and stockholder of Novel Inspiration, while the shares themselves are owned directly by Novel Inspiration.

IRIDEX Corp reported an insider ownership change involving a major shareholder. On July 1, 2025, Novel Inspiration International Co., Ltd., identified as a 10% owner of IRIDEX (IRIX), was issued 137,333 shares of common stock.

The Form 4 states that these shares were issued as a quarterly interest payment on a Convertible Promissory Note dated March 19, 2025 between IRIDEX and Novel Inspiration. The shares were received at a stated price of $0.00 per share, and the filing shows 137,333 shares beneficially owned following the transaction, held directly by Novel Inspiration.

The report is filed jointly by Novel Inspiration and Shih-Yao David Lin, who is described as the sole officer, director and stockholder of Novel Inspiration, linking his interests to this 10% ownership position.

IRIDEX Corp reported that Novel Inspiration International Co., Ltd. and Shih‑Yao David Lin are 10% owners via preferred stock and a convertible note. As of March 19, 2025, Novel Inspiration held 600,000 shares of Series B Preferred Stock and a convertible promissory note convertible into 400,000 additional Series B Preferred shares, all owned directly by Novel Inspiration.

Each Series B Preferred share is convertible, at Novel Inspiration’s option, into five shares of common stock with no expiration date, representing 3,000,000 common shares from the existing preferred and a further 2,000,000 common shares from the note. Before required stockholder approval, Novel Inspiration could convert only into 3,356,126 common shares, equal to 19.99% of IRIDEX’s outstanding common stock as of March 19, 2025, and that approval was obtained on June 11, 2025.

Novel Inspiration International Co., Ltd. and Shih‑Yao David Lin report beneficial ownership of 5,351,483 IRIDEX Corporation shares, or 24.1% of the common stock. Their position comes from 600,000 shares of Series B Preferred Stock purchased at $10.00 per share and a $4,000,000 convertible promissory note, both convertible into a total of 5,000,000 common shares, plus 351,483 common shares issued as interest on the note. The note carries 12% annual interest, payable quarterly in common stock based on a formula tied to market price and a minimum price of $0.21 per share.

Novel Inspiration and Mr. Lin describe the investment as for investment purposes but indicate plans to engage with IRIDEX’s board and management on strategy, capital structure, and potential transactions, including possible mergers, acquisitions, or a going‑private deal. An Investor Rights Agreement gives Novel Inspiration registration rights, the ability—subject to ownership thresholds—to appoint up to two directors, and approval rights over certain corporate actions, increasing their potential influence over the company’s governance and strategic direction.

IRIDEX Corporation director reports open-market stock purchase

A director of IRIDEX Corporation reported buying 2,000 shares of common stock on 12/16/2025 at a price of $1.0099 per share. After this transaction, the director beneficially owns 251,550 shares directly and 69,300 shares indirectly through a spouse. An additional 81,150 shares are held indirectly through the William M. Moore Trust and the Patricia A. Moore Trust, which hold the shares as tenants in common under trust agreements dated August 16, 2016 and August 17, 2016, respectively.

IRIDEX director William M. Moore reported buying 20,000 shares of IRIDEX common stock on 12/15/2025, shown as a purchase transaction.

The shares were acquired in multiple trades at weighted average prices between $0.98 and $0.9885 per share. Following this transaction, Moore directly owned 249,550 IRIDEX shares, with an additional 69,300 shares held indirectly by his spouse and 81,150 shares held indirectly through the William M. Moore Trust and the Patricia A. Moore Trust as tenants in common.

Iridex Corp director reported buying additional company common stock in December 2025. On December 11, 2025, the director purchased 9,080 shares at a weighted average price between $0.9508 and $0.97. On December 12, 2025, the director purchased a further 20,920 shares at a weighted average price between $0.9205 and $0.97, bringing direct beneficial ownership to 280,674 shares of Iridex common stock.

The report also discloses indirect holdings of 69,300 shares held by the director’s spouse and 30,026 shares held through the William M. Moore Trust and the Patricia A. Moore Trust as tenants in common.

IRIDEX Corp's chief financial officer, Romeo R. Dizon, reported acquiring 2,365 shares of common stock on 12/12/2025 at $0.9709 per share. Following this purchase, his direct ownership increased to 92,685 IRIDEX common shares, as disclosed in the Form 4 insider transaction report.

IRIDEX Corporation filed a current report to highlight its participation in the Sidoti Year-End Virtual Investor Conference on December 11, 2025. A live webcast of the presentation is scheduled to begin at 10:45 a.m. Eastern Time and will be available, along with an archived version, in the investors section of the company’s website at www.IRIDEX.com.

The company is also making available a set of presentation materials as Exhibit 99.1. These materials are being furnished, not filed, under Regulation FD, meaning they are shared for information purposes and are not treated as part of the company’s formal financial reporting under Section 18 of the Exchange Act.